BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32380696)

  • 1. RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia.
    Gassner FJ; Zaborsky N; Feldbacher D; Greil R; Geisberger R
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
    Van Roosbroeck K; Calin GA
    Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2016 Nov; 49(16-17):1307-1310. PubMed ID: 27544753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
    Gassner FJ; Zaborsky N; Buchumenski I; Levanon EY; Gatterbauer M; Schubert M; Rauscher S; Hebenstreit D; Nadeu F; Campo E; Egle A; Greil R; Geisberger R
    Leukemia; 2021 Apr; 35(4):1053-1063. PubMed ID: 32728184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
    Patz M; Pallasch CP; Wendtner CM
    Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia.
    Martin-Guerrero I; Gutierrez-Camino A; Lopez-Lopez E; Bilbao-Aldaiturriaga N; Pombar-Gomez M; Ardanaz M; Garcia-Orad A
    PLoS One; 2015; 10(3):e0118905. PubMed ID: 25793711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
    Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
    Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
    Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
    Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR Mediated RNA Editing Modulates MicroRNA Targeting in Human Breast Cancer.
    Roberts JT; Patterson DG; King VM; Amin SV; Polska CJ; Houserova D; Crucello A; Barnhill EC; Miller MM; Sherman TD; Borchert GM
    Processes (Basel); 2018 May; 6(5):. PubMed ID: 30197877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
    Nana-Sinkam SP; Croce CM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
    Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
    Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis.
    Javandoost E; Firoozi-Majd E; Rostamian H; Khakpoor-Koosheh M; Mirzaei HR
    Curr Med Chem; 2020; 27(2):282-297. PubMed ID: 31544709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanisms of regulation of miRNAs in CLL.
    Balatti V; Acunzo M; Pekarky Y; Croce CM
    Trends Cancer; 2016 Mar; 2(3):134-143. PubMed ID: 27213184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.
    Ferrajoli A; Ivan C; Ciccone M; Shimizu M; Kita Y; Ohtsuka M; D'Abundo L; Qiang J; Lerner S; Nouraee N; Rabe KG; Rassenti LZ; Van Roosbroeck K; Manning JT; Yuan Y; Zhang X; Shanafelt TD; Wierda WG; Sabbioni S; Tarrand JJ; Estrov Z; Radovich M; Liang H; Negrini M; Kipps TJ; Kay NE; Keating M; Calin GA
    EBioMedicine; 2015 Jun; 2(6):572-82. PubMed ID: 26288818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.